Helicobacter pylori diversity and gastric cancer risk

mBio

Volumn 7, Issue 1, 2016, Pages

  Cover, Timothy L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; DUPA PROTEIN; INTERLEUKIN 1BETA; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

CAG PATHOGENICITY ISLAND; CANCER INCIDENCE; CANCER RISK; COMMENSALISM; CYTOKINE PRODUCTION; GENETIC RECOMBINATION; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHICAL VARIATION (SPECIES); HELICOBACTER INFECTION; HUMAN; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; REVIEW; SALT INTAKE; STOMACH CANCER; STOMACH CARCINOGENESIS; STRAIN DIFFERENCE; SYMBIOSIS; TYPE IV SECRETION SYSTEM; ANIMAL; CLASSIFICATION; COMPLICATION; DISEASE MODEL; GENETIC VARIATION; GENETICS; GENOMIC ISLAND; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; RISK ASSESSMENT; STOMACH NEOPLASMS;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC VARIATION; GENOMIC ISLANDS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; RISK ASSESSMENT; STOMACH NEOPLASMS; VIRULENCE FACTORS;

EID: 84960145647     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01869-15     Document Type: Review

References (114)

1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. 2012. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615. http://dx.doi.org/10.1016/S1470-2045(12)70137-7.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. 2001. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789. http://dx.doi.org/10.1056/NEJMoa001999.
3. de Martel C, Forman D, Plummer M. 2013. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 42:219–240. http://dx.doi.org/10.1016/j.gtc.2013.01.003.
4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2012. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:-1–441.
5. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. 1998. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115:642–648. http://dx.doi.org/10.1016/S0016-5085(98)70143-X.
6. Peek RM, Blaser MJ. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2:28–37. http://dx.doi.org/10.1038/nrc703.
7. Fox JG, Wang TC. 2007. Inflammation, atrophy, and gastric cancer. J Clin Invest 117:60–69. http://dx.doi.org/10.1172/JCI30111.
8. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. 2013. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13:759–771. http://dx.doi.org/10.1038/nrc3611.
9. Cover TL, Blaser MJ. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863–1873. http://dx.doi.org/10.1053/j.gastro.2009.01.073.
10. Blaser MJ, Berg DE. 2001. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 107:767–773. http://dx.doi.org/10.1172/JCI12672.
11. Suerbaum S, Josenhans C. 2007. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol 5:441–452. http://dx.doi.org/10.1038/nrmicro1658.
12. Suerbaum S, Smith JM, Bapumia K, Morelli G, Smith NH, Kunstmann E, Dyrek I, Achtman M. 1998. Free recombination within Helicobacter pylori. Proc Natl Acad Sci U S A 95:12619–12624. http://dx.doi.org/10.1073/pnas.95.21.12619.
13. Morelli G, Didelot X, Kusecek B, Schwarz S, Bahlawane C, Falush D, Suerbaum S, Achtman M. 2010. Microevolution of Helicobacter pylori during prolonged infection of single hosts and within families. PLoS Genet 6:e1001036. http://dx.doi.org/10.1371/journal.pgen.1001036.
14. Olbermann P, Josenhans C, Moodley Y, Uhr M, Stamer C, Vauterin M, Suerbaum S, Achtman M, Linz B. 2010. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet 6:e1001069. http://dx.doi.org/10.1371/journal.pgen.1001069.
15. Fischer W. 2011. Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus. FEBS J 278:1203–1212. http://dx.doi.org/10.1111/j.1742-4658.2011.08036.x.
16. Tegtmeyer N, Wessler S, Backert S. 2011. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J 278:1190–1202. http://dx.doi.org/10.1111/j.1742-4658.2011.08035.x.
17. Hatakeyama M. 2014. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe 15: 306–316. http://dx.doi.org/10.1016/j.chom.2014.02.008.
18. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Mémet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5:1166–1174. http://dx.doi.org/10.1038/ni1131.
19. Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500. http://dx.doi.org/10.1126/science.287.5457.1497.
20. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A 96: 14559–14564. http://dx.doi.org/10.1073/pnas.96.25.14559.
21. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, Ohno S, Hatakeyama M. 2007. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447:330–333. http://dx.doi.org/10.1038/nature05765.
22. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430–1434. http://dx.doi.org/10.1126/science.1081919.
23. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. 2005. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 102:16339–16344. http://dx.doi.org/10.1073/pnas.0502598102.
24. Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman RH, Kersulyte D, Berg DE, Sasakawa C. 2009. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5:23–34. http://dx.doi.org/10.1016/j.chom.2008.11.010.
25. Neal JT, Peterson TS, Kent ML, Guillemin K. 2013. H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model. Dis Models Mech 6:802–810. http://dx.doi.org/10.1242/dmm.011163.
26. Sigal M, Rothenberg ME, Logan CY, Lee JY, Honaker RW, Cooper RL, Passarelli B, Camorlinga M, Bouley DM, Alvarez G, Nusse R, Torres J, Amieva MR. 2015. Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands. Gastroenterology 148: 1392–1404.e21. http://dx.doi.org/10.1053/j.gastro.2015.02.049.
27. Buti L, Spooner E, Van der Veen AG, Rappuoli R, Covacci A, Ploegh HL. 2011. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A 108:9238–9243. http://dx.doi.org/10.1073/pnas.1106200108.
28. Rieder G, Merchant JL, Haas R. 2005. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128:1229–1242. http://dx.doi.org/10.1053/j.gastro.2005.02.064.
29. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM, Jr. 2008. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 68:379–387. http://dx.doi.org/10.1158/0008-5472.CAN-07-0824.
30. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC, Tan S, Morgan DR, Wilson KT, Bravo LE, Correa P, Cover TL, Amieva MR, Peek RM, Jr. 2013. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest 123:479–492. http://dx.doi.org/10.1172/JCI64373.
31. Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM, Jr., Algood HM, Cover TL. 2013. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect Immun 81: 2258–2267. http://dx.doi.org/10.1128/IAI.01271-12.
32. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M. 2008. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A 105:1003–1008. http://dx.doi.org/10.1073/pnas.0711183105.
33. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111–2115.
34. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simões M. 2002. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94:1680–1687. http://dx.doi.org/10.1093/jnci/94.22.1680.
35. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, Lopez G, Colin D, Muñoz N, Kato I. 2007. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 99:1328–1334. http://dx.doi.org/10.1093/jnci/djm120.
36. Suzuki N, Murata-Kamiya N, Yanagiya K, Suda W, Hattori M, Kanda H, Bingo A, Fujii Y, Maeda S, Koike K, Hatakeyama M. 2015. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein. Sci Rep 5:10024. http://dx.doi.org/10.1038/srep10024.
37. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad SciUS A 99:14428–14433. http://dx.doi.org/10.1073/pnas.222375399.
38. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. 2004. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127:514–523. http://dx.doi.org/10.1053/j.gastro.2004.06.006.
39. Nagase L, Hayashi T, Senda T, Hatakeyama M. 2015. Dramatic increase in SHP2 binding activity of Helicobacter pylori western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis. Sci Rep 5:15749. http://dx.doi.org/10.1038/srep15749.
40. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, Dojo M, Yamazaki Y, Kuriyama M. 2002. Correlation between variation of the 3= region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 186:1621–1630. http://dx.doi.org/10.1086/345374.
41. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, Rugge M, Plebani M, Atherton JC. 2008. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135:91–99. http://dx.doi.org/10.1053/j.gastro.2008.03.041.
42. Zhang XS, Tegtmeyer N, Traube L, Jindal S, Perez-Perez G, Sticht H, Backert S, Blaser MJ. 2015. A specific A/T polymorphism in western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions. PLoS Pathog 11:e1004621. http://dx.doi.org/10.1371/journal.ppat.1004621.
43. Loh JT, Shaffer CL, Piazuelo MB, Bravo LE, McClain MS, Correa P, Cover TL. 2011. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev 20: 2237–2249. http://dx.doi.org/10.1158/1055-9965.EPI-11-0548.
44. Ferreira RM, Pinto-Ribeiro I, Wen X, Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Figueiredo C. 23 September 2015. Helicobacter pylori cagA promoter region sequences influence CagA expression and interleukin 8 secretion. J Infect Dis. http://dx.doi.org/10.1093/infdis/jiv467.
45. Cover TL, Blanke SR. 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 3:320–332. http://dx.doi.org/10.1038/nrmicro1095.
46. Boquet P, Ricci V. 2012. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol 20:165–174. http://dx.doi.org/10.1016/j.tim.2012.01.008.
47. Kim IJ, Blanke SR. 2012. Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front Cell Infect Microbiol 2:37. http://dx.doi.org/10.3389/fcimb.2012.00037.
48. Cover TL, Blaser MJ. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 267: 10570–10575.
49. Gangwer KA, Mushrush DJ, Stauff DL, Spiller B, McClain MS, Cover TL, Lacy DB. 2007. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc Natl Acad SciUSA104:16293–16298. http://dx.doi.org/10.1073/pnas.0707447104.
50. Forsyth MH, Atherton JC, Blaser MJ, Cover TL. 1998. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infect Immun 66:3088–3094.
51. Atherton JC, Cao P, Peek RM,, Tummuru MK, Blaser MJ, Cover TL. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270:17771–17777.
52. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. 2007. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133:926–936. http://dx.doi.org/10.1053/j.gastro.2007.06.056.
53. Gangwer KA, Shaffer CL, Suerbaum S, Lacy DB, Cover TL, Bordenstein SR. 2010. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J Bacteriol 192:6126–6135. http://dx.doi.org/10.1128/JB.01081-10.
54. McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, Shao Z, Cover TL. 2001. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol 183:6499–6508. http://dx.doi.org/10.1128/JB.183.22.6499-6508.2001.
55. Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC. 2003. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J Biol Chem 278:26734–26741. http://dx.doi.org/10.1074/jbc.M304071200.
56. Willhite DC, Blanke SR. 2004. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell Microbiol 6:143–154. http://dx.doi.org/10.1046/j.1462-5822.2003.00347.x.
57. Gauthier NC, Monzo P, Gonzalez T, Doye A, Oldani A, Gounon P, Ricci V, Cormont M, Boquet P. 2007. Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin. J Cell Biol 177:343–354. http://dx.doi.org/10.1083/jcb.200609061.
58. Calore F, Genisset C, Casellato A, Rossato M, Codolo G, Esposti MD, Scorrano L, de Bernard M. 2010. Endosome-mitochondria juxtaposition during apoptosis induced by H. pylori VacA. Cell Death Differ 17: 1707–1716. http://dx.doi.org/10.1038/cdd.2010.42.
59. Satin B, Norais N, Telford J, Rappuoli R, Murgia M, Montecucco C, Papini E. 1997. Effect of Helicobacter pylori vacuolating toxin on maturation and extracellular release of procathepsin D and on epidermal growth factor degradation. J Biol Chem 272:25022–25028. http://dx.doi.org/10.1074/jbc.272.40.25022.
60. Terebiznik MR, Raju D, Vázquez CL, Torbricki K, Kulkarni R, Blanke SR, Yoshimori T, Colombo MI, Jones NL. 2009. Effect of Helicobacter pylori’s vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 5:370–379. http://dx.doi.org/10.4161/auto.5.3.7663.
61. Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, Nagano O, Matsuzaki J, Hibi T. 2012. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 12:764–777. http://dx.doi.org/10.1016/j.chom.2012.10.014.
62. Wang F, Xia P, Wu F, Wang D, Wang W, Ward T, Liu Y, Aikhionbare F, Guo Z, Powell M, Liu B, Bi F, Shaw A, Zhu Z, Elmoselhi A, Fan D, Cover TL, Ding X, Yao X. 2008. Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem 283:26714–26725. http://dx.doi.org/10.1074/jbc.M800527200.
63. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099–1102. http://dx.doi.org/10.1126/science.1086871.
64. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A 101:7727–7732. http://dx.doi.org/10.1073/pnas.0401528101.
65. Winter JA, Letley DP, Cook KW, Rhead JL, Zaitoun AA, Ingram RJ, Amilon KR, Croxall NJ, Kaye PV, Robinson K, Atherton JC. 2014. A role for the vacuolating cytotoxin, VacA, in colonization and Helicobacter pylori-induced metaplasia in the stomach. J Infect Dis 210:954–963. http://dx.doi.org/10.1093/infdis/jiu154.
66. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Borén T. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373–377. http://dx.doi.org/10.1126/science.279.5349.373.
67. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, Altraja S, Wadstrom T, Kersulyte D, Berg DE, Dubois A, Petersson C, Magnusson KE, Norberg T, Lindh F, Lundskog BB, Arnqvist A, Hammarstrom L, Boren T. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297:573–578. http://dx.doi.org/10.1126/science.1069076.
68. Aspholm M, Olfat FO, Nordén J, Sondén B, Lundberg C, Sjöström R, Altraja S, Odenbreit S, Haas R, Wadström T, Engstrand L, Semino-Mora C, Liu H, Dubois A, Teneberg S, Arnqvist A, Borén T. 2006. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog 2:e110. http://dx.doi.org/10.1371/journal.ppat.0020110.
69. Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. 1999. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 96:12778–12783. http://dx.doi.org/10.1073/pnas.96.22.12778.
70. Prinz C, Schöniger M, Rad R, Becker I, Keiditsch E, Wagenpfeil S, Classen M, Rösch T, Schepp W, Gerhard M. 2001. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 61:1903–1909.
71. Yu J, Leung WK, Go MY, Chan MC, To KF, Ng EK, Chan FK, Ling TK, Chung SC, Sung JJ. 2002. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 51:480–484. http://dx.doi.org/10.1136/gut.51.4.480.
72. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY. 2006. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55: 775–781. http://dx.doi.org/10.1136/gut.2005.083014.
73. Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth HP, Blaser MJ, Berg DE, Gordon JI. 1998. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A 95:3925–3930. http://dx.doi.org/10.1073/pnas.95.7.3925.
74. Oleastro M, Cordeiro R, Ferrand J, Nunes B, Lehours P, Carvalho-Oliveira I, Mendes AI, Penque D, Monteiro L, Mégraud F, Ménard A. 2008. Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis 198:1379–1387. http://dx.doi.org/10.1086/592166.
75. Cao P, Cover TL. 2002. Two different families of hopQ alleles in Helicobacter pylori. J Clin Microbiol 40:4504–4511. http://dx.doi.org/10.1128/JCM.40.12.4504-4511.2002.
76. Jung SW, Sugimoto M, Graham DY, Yamaoka Y. 2009. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol 47:3241–3245. http://dx.doi.org/10.1128/JCM.00293-09.
77. Talebi Bezmin Abadi A, Rafiei A, Ajami A, Hosseini V, Taghvaei T, Jones KR, Merrell DS. 2011. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol 49:3191–3197. http://dx.doi.org/10.1128/JCM.00947-11.
78. Yakoob J, Abbas Z, Khan R, Salim SA, Awan S, Abrar A, Jafri W. 2016. Helicobacter pylori outer membrane protein Q allele distribution is associated with distinct pathologies in Pakistan. Infect Genet Evol 37:57–62. http://dx.doi.org/10.1016/j.meegid.2015.10.027.
79. Yamaoka Y, Kita M, Kodama T, Imamura S, Ohno T, Sawai N, Ishimaru A, Imanishi J, Graham DY. 2002. Helicobacter pylori infection in mice: role of outer membrane proteins in colonization and inflammation. Gastroenterology 123:1992–2004. http://dx.doi.org/10.1053/gast.2002.37074.
80. Belogolova E, Bauer B, Pompaiah M, Asakura H, Brinkman V, Ertl C, Bartfeld S, Nechitaylo TY, Haas R, Machuy N, Salama N, Churin Y, Meyer TF. 2013. Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell Microbiol 15:1896–1912. http://dx.doi.org/10.1111/cmi.12158.
81. Dossumbekova A, Prinz C, Mages J, Lang R, Kusters JG, van Vliet AH, Reindl W, Backert S, Saur D, Schmid RM, Rad R. 2006. Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis 194: 1346–1355. http://dx.doi.org/10.1086/508426.
82. Yamaoka Y. 2010. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 7:629–641. http://dx.doi.org/10.1038/nrgastro.2010.154.
83. Odenbreit S, Swoboda K, Barwig I, Ruhl S, Borén T, Koletzko S, Haas R. 2009. Outer membrane protein expression profile in Helicobacter py-lori clinical isolates. Infect Immun 77:3782–3790. http://dx.doi.org/10.1128/IAI.00364-09.
84. Lu H, Hsu PI, Graham DY, Yamaoka Y. 2005. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128:833–848. http://dx.doi.org/10.1053/j.gastro.2005.01.009.
85. Abadi AT, Taghvaei T, Wolfram L, Kusters JG. 2012. Infection with Helicobacter pylori strains lacking dupA is associated with an increased risk of gastric ulcer and gastric cancer development. J Med Microbiol 61:23–30. http://dx.doi.org/10.1099/jmm.0.027052-0.
86. Hussein NR, Argent RH, Marx CK, Patel SR, Robinson K, Atherton JC. 2010. Helicobacter pylori dupA is polymorphic, and its active form induces proinflammatory cytokine secretion by mononuclear cells. J Infect Dis 202:261–269. http://dx.doi.org/10.1086/653587.
87. Queiroz DM, Rocha GA, Rocha AM, Moura SB, Saraiva IE, Gomes LI, Soares TF, Melo FF, Cabral MM, Oliveira CA. 2011. dupA polymorphisms and risk of Helicobacter pylori-associated diseases. Int J Med Microbiol 301:225–228. http://dx.doi.org/10.1016/j.ijmm.2010.08.019.
88. Van Doorn LJ, Figueiredo C, Mégraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R, De Boer W, Schneeberger PM, Correa P, Ng EK, Atherton J, Blaser MJ, Quint WG. 1999. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116:823–830. http://dx.doi.org/10.1016/S0016-5085(99)70065-X.
89. Hennig EE, Allen JM, Cover TL. 2006. Multiple chromosomal loci for the babA gene in Helicobacter pylori. Infect Immun 74:3046–3051. http://dx.doi.org/10.1128/IAI.74.5.3046-3051.2006.
90. Tan S, Noto JM, Romero-Gallo J, Peek RM, Jr., Amieva MR. 2011. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 7:e1002050. http://dx.doi.org/10.1371/journal.ppat.1002050.
91. Argent RH, Thomas RJ, Letley DP, Rittig MG, Hardie KR, Atherton JC. 2008. Functional association between the Helicobacter pylori virulence factors VacA and CagA. J Med Microbiol 57:145–150. http://dx.doi.org/10.1099/jmm.0.47465-0.
92. Yokoyama K, Higashi H, Ishikawa S, Fujii Y, Kondo S, Kato H, Azuma T, Wada A, Hirayama T, Aburatani H, Hatakeyama M. 2005. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci U S A 102:9661–9666. http://dx.doi.org/10.1073/pnas.0502529102.
93. Oldani A, Cormont M, Hofman V, Chiozzi V, Oregioni O, Canonici A, Sciullo A, Sommi P, Fabbri A, Ricci V, Boquet P. 2009. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog 5:e1000603. http://dx.doi.org/10.1371/journal.ppat.1000603.
94. Tegtmeyer N, Zabler D, Schmidt D, Hartig R, Brandt S, Backert S. 2009. Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA. Cell Microbiol 11:488–505. http://dx.doi.org/10.1111/j.1462-5822.2008.01269.x.
95. Ishijima N, Suzuki M, Ashida H, Ichikawa Y, Kanegae Y, Saito I, Borén T, Haas R, Sasakawa C, Mimuro H. 2011. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J Biol Chem 286:25256–25264. http://dx.doi.org/10.1074/jbc.M111.233601.
96. Marcos NT, Magalhães A, Ferreira B, Oliveira MJ, Carvalho AS, Mendes N, Gilmartin T, Head SR, Figueiredo C, David L, Santos-Silva F, Reis CA. 2008. Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J Clin Invest 118:2325–2336. http://dx.doi.org/10.1172/JCI34324.
97. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. 1997. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 35:1710–1714.
98. Lai CH, Kuo CH, Chen YC, Chao FY, Poon SK, Chang CS, Wang WC. 2002. High prevalence of cagA_ and babA2-positive Helicobacter pylori clinical isolates in Taiwan. J Clin Microbiol 40:3860–3862. http://dx.doi.org/10.1128/JCM.40.10.3860-3862.2002.
99. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, Blaser MJ, Graham DY, Vacher S, Perez-Perez GI, Yamaoka Y, Mégraud F, Otto K, Reichard U, Katzowitsch E, Wang X, Achtman M, Suerbaum S. 2003. Traces of human migrations in Helicobacter pylori populations. Science 299:1582–1585. http://dx.doi.org/10.1126/science.1080857.
100. Duncan SS, Valk PL, McClain MS, Shaffer CL, Metcalf JA, Bordenstein SR, Cover TL. 2013. Comparative genomic analysis of East Asian and non-Asian Helicobacter pylori strains identifies rapidly evolving genes. PLoS One 8:e55120. http://dx.doi.org/10.1371/journal.pone.0055120.
101. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, Ito Y, Dojo M, Yamazaki Y, Kuriyama M, Keida Y, Higashi H, Hatakeyama M. 2004. Association between diversity in the Src homology 2 domain—containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 189: 820–827. http://dx.doi.org/10.1086/381782.
102. Suzuki M, Kiga K, Kersulyte D, Cok J, Hooper CC, Mimuro H, Sanada T, Suzuki S, Oyama M, Kozuka-Hata H, Kamiya S, Zou QM, Gilman RH, Berg DE, Sasakawa C. 2011. Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem 286:29964–29972. http://dx.doi.org/10.1074/jbc.M111.263715.
103. Jones KR, Joo YM, Jang S, Yoo YJ, Lee HS, Chung IS, Olsen CH, Whitmire JM, Merrell DS, Cha JH. 2009. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol 47:959–968. http://dx.doi.org/10.1128/JCM.02330-08.
104. Lu H, Wu JY, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y. 2007. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem 282:6242–6254. http://dx.doi.org/10.1074/jbc.M611178200.
105. McLean MH, El-Omar EM. 2014. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 11:664–674. http://dx.doi.org/10.1038/nrgastro.2014.143.
106. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Chow WH. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124:1193–1201. http://dx.doi.org/10.1016/S0016-5085(03)00157-4.
107. Kato I, van Doorn LJ, Canzian F, Plummer M, Franceschi S, Vivas J, Lopez G, Lu Y, Gioia-Patricola L, Severson RK, Schwartz AG, Muñoz N. 2006. Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer 119:1666–1671. http://dx.doi.org/10.1002/ijc.21979.
108. Cover TL, Peek RM, Jr. 2013. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes 4:482–493. http://dx.doi.org/10.4161/gmic.26262.
109. Loh JT, Torres VJ, Cover TL. 2007. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 67:4709–4715. http://dx.doi.org/10.1158/0008-5472.CAN-06-4746.
110. Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, Schlebusch CM, Bernhöft S, Hale J, Suerbaum S, Mugisha L, van der Merwe SW, Achtman M. 2012. Age of the association between Helicobacter pylori and man. PLoS Pathog 8:e1002693. http://dx.doi.org/10.1371/journal.ppat.1002693.
111. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, Achtman M. 2007. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445:915–918. http://dx.doi.org/10.1038/nature05562.
112. Kodaman N, Pazos A, Schneider BG, Piazuelo MB, Mera R, Sobota RS, Sicinschi LA, Shaffer CL, Romero-Gallo J, de Sablet T, Harder RH, Bravo LE, Peek RM, Wilson KT, Cover TL, Williams SM, Correa P. 2014. Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A 111:1455–1460. http://dx.doi.org/10.1073/pnas.1318093111.
113. Jiménez-Soto LF, Clausen S, Sprenger A, Ertl C, Haas R. 2013. Dynamics of the Cag-type IV secretion system of Helicobacter pylori as studied by bacterial co-infections. Cell Microbiol 15:1924–1937. http://dx.doi.org/10.1111/cmi.12166.
114. Secka O, Antonio M, Berg DE, Tapgun M, Bottomley C, Thomas V, Walton R, Corrah T, Thomas JE, Adegbola RA. 2011. Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia. PLoS One 6:e27954. http://dx.doi.org/10.1371/journal.pone.0027954.